No - not yet.
Pradaxa is approved to prevent strokes and "systemic embolism" (blood clots) in people with atrial fibrillation.
Other "off label" (unapproved) uses include:
Preventing stroke and blood clots in people with heart valve disease
Preventing or treating blood clots in people undergoing surgeries
Preventing or treating blood clots in people with cancer
Preventing or treating deep vein thrombosis (DVT)
Preventing or treating pulmonary embolism (PE), a blood clot in the lungs.
For more information see: https://www.drugs.com/pro/pradaxa.html
- Pradaxa Information for Consumers
- Pradaxa Information for Healthcare Professionals (includes dosage details)
- Side Effects of Pradaxa (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 22 Aug 2009 • 2 answers
Posted 11 May 2011 • 1 answer
Posted 7 Jan 2013 • 1 answer
Posted 2 May 2016 • 1 answer
Posted 23 Nov 2016 • 0 answers